Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 11, Issue 11, Pages 1043-1049Publisher
WILEY
DOI: 10.1093/eurjhf/hfp127
Keywords
Natriuretic peptides; Heart failure; Dyspnoea; Cardiovascular disease; Net reclassification improvement
Categories
Funding
- Inovise Medical Inc
Ask authors/readers for more resources
We sought to create a model that adjusts B-type natriuretic peptide (BNP) for specific covariates to better distinguish cardiac from non-cardiac dyspnoea. HEARD-IT was a multicentre, prospective study of the diagnostic utility of acoustic cardiography in the emergency department. Dyspnoeic patients more than 40 years were eligible. Two cardiologists independently adjudicated the HF outcome. Using logistic regression, a model adjusting BNP for pertinent covariates was developed (n = 740). The mean age was 66 +/- 13 years. Age, gender, ethnicity, body mass index, blood urea nitrogen, and creatinine affected BNP levels independently of HF. The model adjusting BNP for these covariates improved the area under receiver operator characteristic curve for HF compared with BNP alone (0.948, 95% CI 0.934-0.963 vs. 0.937, 95% CI 0.920-0.954; P = 0.004). Net reclassification improvement, a novel metric of model performance, was 3.5% for those without HF (P = 0.05) compared with conventional, unadjusted BNP cut-offs. Thirteen of 116 (11%) patients without HF, but with unadjusted BNP values >= 100 pg/mL, were correctly reclassified as not having HF with the adjusted BNP model. Adjusting BNP for important covariates may improve its ability to distinguish cardiac from non-cardiac dyspnoea.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available